Intervention
Sham stimulation
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 29 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
29 shownTIS for Improving Cognitive Impairment in SchizophreniaNCT07647380 · 2026-06-24
RECRUITINGNon-invasive Brain Stimulation Using Tdcs of the Third (of Many) Visual PathwaysNCT07469384 · 2026-02-01
RECRUITINGtVNS, Motivation, and Insulin SensitivityNCT07198100 · 2025-10-10
RECRUITINGPeripheral Magnetic Stimulation With Balance Training to Decrease Fall Risks in Diabetic PolyneuropathyNCT07000214 · 2025-06-10
RECRUITINGTemporal Interference and DepressionNCT05295888 · 2025-05-15
RECRUITINGSCS for Patient With Painful Diabetic Neuropathy and Peripheral Arterial DiseaseNCT06480786 · 2024-12-18
RECRUITINGnTMS for Negative Symptom in SchizophreniaNCT06642675 · 2024-11-22
RECRUITINGThe Safety and Effectiveness of dTMS for Reducing Antipsychotic-induced Weight GainNCT07795554 · 2026-09-01
NOT_YET_RECRUITINGNeuromodulation in Patients With Pulmonary Arterial HypertensionNCT06802380 · 2025-09-01
NOT_YET_RECRUITINGTranscutaneous Electrical Acupoint Stimulation on Blood PressureNCT06537167 · 2025-08-01
NOT_YET_RECRUITINGSleep Modulation to Treat DepressionNCT06443216 · 2024-07-22
UNKNOWNNon-invasive Vagus Nerve Stimulation as a Tool to Modulate Stomach-Brain Coupling in DepressionNCT06389175 · 2024-05-21
ENROLLING_BY_INVITATIONEffectiveness of TTNS in MS Patients With Lower Urinary Track SymptomsNCT06263556 · 2024-01-17
UNKNOWNEffect of TTNS and PNS on Neurogenic Overactive Bladder Symptoms in Female Patients With Multiple Sclerosis.NCT06143397 · 2023-11-20
COMPLETEDEffects of rTSMS Associated With Treadmill Training in Patients With Parkinson's DiseaseNCT05938673 · 2023-06-01
COMPLETEDTENS in Persons With MSNCT05321927 · 2023-01-05
COMPLETEDAt Home Gamma tACS in Alzheimer's Disease (tACS@Home)NCT05643326 · 2022-12-10
COMPLETEDiTBS on Negative Symptoms and Cognitive Function in SchizophreniaNCT05137158 · 2022-10-15
COMPLETEDAccelerated cTBS on Metabolic Dysfunction in People With SchizophreniaNCT05358899 · 2022-06-01
UNKNOWNCognitive Dysfunction in the Addictions Study - Project 4 (P4)NCT06299787 · 2022-02-07
UNKNOWNSimultaneous DBS of the GPi and the NBM in Patients With Parkinson's Disease and Mild Cognitive ImpairmentNCT05320523 · 2021-07-20
UNKNOWNSacral Nerve Stimulation for Mild-to-Moderate or Refractory Rheumatoid ArthritisNCT04821050 · 2021-03-01
UNKNOWNtDCS and Cognitive Efficiency in AgeingNCT05216315 · 2020-07-30
COMPLETEDTreatment of Mild Cognitive Impairment With Transcutaneous Vagal Nerve StimulationNCT03359902 · 2018-01-01
COMPLETEDEffects of Acupuncture Stimulation on Systemic InflammationNCT02951611 · 2016-11-01
UNKNOWNDBS of the MLR for Gait and Balance Disorders in PD PatientsNCT02931097 · 2016-10-01
COMPLETEDTranscranial Current Stimulation as a Treatment for Auditory Hallucinations in SchizophreniaNCT01963676 · 2014-01-01
COMPLETEDElectrostimulation, Skeletal Muscle Function, and Exercise Capacity in Chronic Obstructive Pulmonary Disease (COPD)NCT00874965 · 2006-12-01
COMPLETEDEffect of Electrostimulation in Chronic Obstructive Pulmonary Disease (COPD)NCT01167283 · 2006-07-01
COMPLETEDCommon conditions
Schizophrenia5Major Depressive Disorder3Mild Cognitive Impairment3Multiple Sclerosis3Alzheimer Disease2Parkinson Disease2Aging1Alcohol Use Disorder1Antipsychotic Induced Weight Gain1Auditory Hallucinations1Chronic Obstructive Pulmonary Disease1Chronic Obstructive Pulmonary Disease (COPD)1Chronic Pain1Chronic Pain Syndrome1Cognitive Impairments1Depressive Disorder, Major1Diabetes Mellitus, Type 21Diabetic Polyneuropathy1Eating Behavior1Gait Disorders, Neurologic1Healthy1Hypertension1Limb Pain1Lower Urinary Tract Symptoms1Major Depressive Disorder (MDD)1
Leading sponsors
Central South University4Institut National de la Santé Et de la Recherche Médicale, France2University of Bonn2University of Sao Paulo General Hospital2Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia1Bakirkoy Dr. Sadi Konuk Research and Training Hospital1Centre for Addiction and Mental Health1Christoph Nissen1Laval University1Nanjing First Hospital, Nanjing Medical University1Nathan Kline Institute for Psychiatric Research1Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization1Queen Savang Vadhana Memorial Hospital, Thailand1RenJi Hospital1Second Xiangya Hospital of Central South University1
Trial status mix
COMPLETED11
RECRUITING7
UNKNOWN7
NOT_YET_RECRUITING3
ENROLLING_BY_INVITATION1
Phase mix
NA27
PHASE22
PHASE11
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.